tirzepatide journal SURMOUNT-MMO: First trial on for overweight/obese without diabetes | Samu Shiva, MD posted on the topic Tirzepatide for Patients with Obesity

State policies that cover CGM through a pharmacy benefit, as opposed to a medical benefit, generally make it easier for people to obtain CGM

However, reduced side-effects at lower doses make it likely there are also reduced therapeutic effects

Semaglutide Injection ($189/mo) is the single-agonist option

Vitamin D3, which is readily manufactured by the body when the skin is exposed to natural sunlight

The safest approach is increasing potassium through food sources first, then supplementing conservatively if needed, always under medical guidance

The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of alzheimers disease